First report of Fasciola hepatica seroprevalence and risk factors in European bison (Bison bonasus)
04 avr. 2025
À propos de cet article
Publié en ligne: 04 avr. 2025
Pages: 227 - 232
Reçu: 07 oct. 2024
Accepté: 24 mars 2025
DOI: https://doi.org/10.2478/jvetres-2025-0020
Mots clés
© 2025 Anna Didkowska et al., published by Sciendo
This work is licensed under the Creative Commons Attribution 4.0 International License.
Fig. 1.

Fig. 2.

Effect of sex and site on Fasciola hepatica seropositivity in European bison_ The age variable was excluded in the model selection procedure
B | SE | Lower CI | Upper CI | Wald chi2 | P-value | |
---|---|---|---|---|---|---|
Intercept | –2.392 | 0.3611 | –3.099 | –1.684 | 43.872 | <0.001 |
Female | 1.090 | 0.3087 | 0.485 | 1.695 | 12.462 | <0.001 |
Male | 0 |
|||||
Lowland location | 1.544 | 0.3433 | 0.872 | 2.217 | 20.243 | <0.001 |
Mountain location | 0 |